Mezzasalma Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.41M | Hold |
|
|||||
|
2025
Q2 | $1.31M | Hold |
|
|||||
|
2025
Q1 | $1.59M | Hold |
|
|||||
|
2024
Q4 | $1.78M | Hold |
|
|||||
|
2024
Q3 | $2.63M | Hold |
|
|||||
|
2024
Q2 | $2.63M | Sell |
|
|||||
|
2024
Q1 | $2.44M | Buy |
|
|||||
|
2023
Q4 | $2.2M | Sell |
|
|||||
|
2023
Q3 | $2.07M | Hold |
|
|||||
|
2023
Q2 | $1.8M | Buy |
|
|||||
|
2023
Q1 | $2.05M | Hold |
|
|||||
|
2022
Q4 | $1.8M | Sell |
|
|||||
|
2022
Q3 | $1.73M | Buy |
|
|||||
|
2022
Q2 | $1.48M | Hold |
|
|||||
|
2022
Q1 | $1.75M | Hold |
|
|||||
|
2021
Q4 | $1.58M | Hold |
|
|||||
|
2021
Q3 | $1.51M | Hold |
|
|||||
|
2021
Q2 | $1.4M | Buy |
|
|||||
|
2021
Q1 | $946K | Buy |
|
|||||
|
2020
Q4 | $483K | Buy |
|